Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
- Regulatory Status
- RUO
- Other Names
- T-Cell Leukemia Antigen, gp40, TP41, T-Cell Surface Antigen Leu-9,LEU-9, P41 Protein, Tp40, T-Cell Antigen CD7
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Immobilized recombinant human CD7 binds to recombinant human SECTM1 in a dose-dependent manner. The ED50 for this effect is 2.5 – 12.5 ng/mL. -
Stability Testing for Recombinant Human CD7. Recombinant human CD7 was aliquoted in PBS, pH 7.2 at 0.2 mg/mL and one aliquot was kept at 4°C (Control), and another was frozen and thawed four times (4x Freeze/Thaw). The samples were tested by their property to bind to recombinant human SECTM1 in a dose-dependent manner. The ED50 for this effect is 2.5 – 12.5 ng/mL.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 588304 | 25 µg | $380 | ||||
| 588306 | 100 µg | $675 | ||||
The CD7 is type I transmembrane glycoprotein of the Ig superfamily with a MW of 40-kD (gp40). It is expressed on T cell precursors, T cells, natural killer (NK) cells, myeloid precursor cells, plasmacytoid dendritic cells (DCs), pre-B cells, and in leukemia cells. Human CD7 is a protein of 240 amino acids and the mature protein includes amino acid 26 to 240. The extracellular domain contains residues 26 to 180. The intracellular domain possesses a YEEM motif. YEEM motif activates the PI3K signaling pathway. Treatment of cells with anti-CD3 or PMA in addition to anti-CD7 demonstrates mitogenic and IL-2 inducing properties of properties of CD7. It has been described that a C7-, CD4+ subpopulation of memory T cells specifically accumulates in skin lesions associated with chronic inflammatory conditions. CD7 is overexpressed in classical Hodgkin lymphoma‐infiltrating T lymphocyte. CD7 is also expressed in T-cell acute lymphoblastic leukemia (T-ALL). CD7 has been used as a novel approach based on chimeric antigen receptor (CAR)–redirected T lymphocytes.
Product DetailsProduct Details
- Source
- Human CD7, amino acid sequence (Ala26-Pro180) (Accession: # P09564), was expressed in 293E cells. The carboxy-terminus contains 8His tag.
- Molecular Mass
- The 166 amino acid recombinant protein has a predicted molecular mass of approximately 17.7 kD. The DTT-reduced and non-reduced proteins migrate at approximately 27 - 31 kD by SDS-PAGE. The predicted N-terminal amino acid is Ala.
- Purity
- > 95%, as determined by Coomassie stained SDS-PAGE.
- Formulation
- 0.22 µm filtered protein solution is in PBS, pH 7.2.
- Endotoxin Level
- Less than 0.1 EU per µg of cytokine as determined by the LAL method.
- Concentration
- 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin the vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Activity
- Immobilized recombinant human CD7 binds recombinant human SECTM1-Fc chimera in a dose-dependent manner. The ED50 for this effect is 2.5 – 12.5 ng/mL.
- Application
-
Bioassay
- Application Notes
-
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.
Antigen Details
- Structure
- Monomer
- Distribution
-
T cells, NK cells, early stages of T cells, myeloid cell precursors, and CD19+ B progenitor cells. Highly expressed on malignant immature T cells. Expressed in monocytes and macrophages
- Function
- Regulation of peripheral T and NK cell cytokine production, functions as a costimulatory receptor for T cell proliferation. CD7 is upregulated in CD4 and CD8 T cells stimulated with anti-CD3 plus anti-CD28.
- Interaction
- CD7 interacts with its ligand SECTM1 in soluble form which is highly expressed by cancer cells.
- Ligand/Receptor
- SECTM1, CTSL
- Bioactivity
- Immobilized recombinant human CD7 binds to recombinant human SECTM1
- Cell Type
- Dendritic cells, Macrophages, Monocytes, NK cells, T cells, Thymocytes, Tregs
- Biology Area
- Adaptive Immunity, Cancer Biomarkers, Cell Biology, Cell Proliferation and Viability, Costimulatory Molecules, Immuno-Oncology
- Molecular Family
- CD Molecules
- Antigen References
-
- Lyman SD, et al. 2000. J Bio Chem. 275:3431-7.
- L Liu, et al. 2000. Clin Exp Immunol. 121:94-9.
- Milush JM, et al. 2009. Blood. 114:4823-31.
- Seegmiller AC, et al. 2009. Cytometry B Clin Cytom. 76:169-74.
- Wang T, et al.2012. J Leukoc Biol. 91:449-59.
- Wang T, et al. 2014. J Invest Dermatol. 134:1108-1118.
- Png YT, et al. 2017. Blood Adv. 1:2348-2360.
- Haftcheshmeh SM. 2019. J Cell Physiol. 234:1179-1189.
- Gene ID
- 924 View all products for this Gene ID
- UniProt
- View information about CD7 on UniProt.org
Related FAQs
- Why choose BioLegend recombinant proteins?
-
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins. - How does the activity of your recombinant proteins compare to competitors?
-
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
-
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
-
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
-
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
-
Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)
Follow Us